Citigroup’s SOC Telemed, Inc. Class A Common Stock TLMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-2,715
Closed -$8K 6925
2022
Q1
$8K Sell
2,715
-198,953
-99% -$438K ﹤0.01% 5663
2021
Q4
$259K Buy
201,668
+191,538
+1,891% +$384K ﹤0.01% 4204
2021
Q3
$23K Buy
10,130
+5,338
+111% +$19.2K ﹤0.01% 5186
2021
Q2
$27K Sell
4,792
-47,307
-91% -$315K ﹤0.01% 5150
2021
Q1
$328K Sell
52,099
-31,830
-38% -$239K ﹤0.01% 3741
2020
Q4
$658K Buy
+83,929
New +$741K ﹤0.01% 3966

Citigroup's TLMD Position: Q2 2022 in Review

Citigroup sold out of SOC Telemed, Inc. Class A Common Stock (TLMD) in Q2 2022, closing a stake of 2,715 shares — an estimated $8K sold.

Citigroup first reported a position in TLMD in Q4 2020 and held it in 6 quarters. The position peaked at $658K in Q4 2020. 0 funds tracked by Wall St. Rank hold TLMD as of Q2 2022.

  • Citigroup reported no remaining SOC Telemed, Inc. Class A Common Stock position as of Q2 2022 after selling out during the quarter.
  • Citigroup sold 2,715 SOC Telemed, Inc. Class A Common Stock shares in Q2 2022, an estimated $8K.
  • Citigroup first reported a position in SOC Telemed, Inc. Class A Common Stock in Q4 2020 and held it in 6 quarters.
  • Citigroup's SOC Telemed, Inc. Class A Common Stock position peaked at $658K in Q4 2020.
  • 0 funds tracked by Wall St. Rank held SOC Telemed, Inc. Class A Common Stock as of Q2 2022.

Based on Citigroup's 13F filing for Q2 2022, filed 10 Aug 2022.